# US 2021/0331998 A1 · Site-specific isotopic labeling of 1,4-diene systems

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0331998 A1
- Document ID: US20210331998A1
- Status: Published application
- Kind: A1
- Application number: 17/369,735
- Filed: 2021-07-07
- Published: 2021-10-28
- Earliest claimed: 2015-11-23
- Assignees: Retrotope, Inc.
- Applicants: Retrotope, Inc.
- Inventors: Dragoslav Vidovic; Mikhail Sergeevich Shchepinov
- Web page: https://patentgrep.com/patent/US20210331998A1

## CPC

- C07C 67/30: by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07B 59/001: {Acyclic or carbocyclic compounds}
- C07C 5/00: Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms
- C07C 11/12: Alkadienes
- C07C 29/00: Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C 51/347: by reactions not involving formation of carboxyl groups
- C07C 69/587: Monocarboxylic acid esters having at least two carbon-to-carbon double bonds
- C07C 407/00: Preparation of peroxy compounds
- A61P 1/16: for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- B01J 2531/822: Rhodium
- C07B 2200/05: Isotopically modified compounds, e.g. labelled
- C07C 2523/46: Ruthenium, rhodium, osmium or iridium
- C07C 2531/22: Organic complexes
- C07C 2531/24: Phosphines
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS

## Abstract

Methods for preparing isotopically modified 1,4-diene systems from non-isotopically modified 1,4-dienes involve selective oxidation of one or more bis-allylic position(s), or the preparation of isotopically modified 1,4-diene systems via trapping pi-allylic complexes with a source of deuterium or tritium. Such methods are useful for preparing isotopically modified polyunsaturated lipid including polyunsaturated fatty acids and polyunsaturated fatty acid derivatives.

## Claims

### Claim 1

(canceled)

### Claim 2

A composition comprising a deuterated polyunsaturated fatty acid or an ester thereof comprising:
a 1,4-polyene system comprising three or more cis double bonds separated from each other by a bis-allylic methylene group and having a mono-allylic methylene group flanking the 1,4-polyene system;
said fatty acid composition comprising on average more than about 80 percent replacement of hydrogen with deuterium at the bis-allylic sites; and
deuteration at the mono-allylic sites provided that said deuteration comprises on average less than about 35 percent replacement of hydrogen with deuterium at the mono-allylic sites.

### Claim 3 (depends on 2)

The composition of claim 2, wherein said fatty acid or ester thereof has an isotopic load of deuterium of greater than 15% said isotopic load being based on the total number of hydrogen/deuterium atoms in said polyunsaturated fatty acid.

### Claim 4 (depends on 2)

The composition of claim 2, wherein said fatty acid or ester thereof has an isotopic load of deuterium of greater than 25% said isotopic load being based on the total number of hydrogen/deuterium atoms in said polyunsaturated fatty acid.

### Claim 5 (depends on 2)

The composition of claim 2, wherein said fatty acid or ester thereof is an omega 3 fatty acid.

### Claim 6 (depends on 2)

The composition of claim 2, wherein said fatty acid or ester thereof is an omega 6 fatty acid or ester thereof.

### Claim 7 (depends on 2)

The composition of claim 2, wherein said fatty acid or ether thereof is an omega 9 fatty acid or ester thereof.

### Claim 8 (depends on 2)

The composition of claim 2, wherein said fatty acid or ester thereof comprises at least about 90 percent replacement of hydrogen with deuterium at the bis-allylic sites.

### Claim 9 (depends on 8)

The composition of claim 8, wherein said fatty acid or ester thereof comprises no more than about 20 percent replacement of hydrogen with deuterium at the mono-allylic sites.

### Claim 10 (depends on 2)

The composition of claim 2, wherein said fatty acid or ester thereof is naturally occurring.

### Claim 11 (depends on 2)

The composition of claim 2, wherein said fatty acid or ester thereof is arachidonic acid or an ester thereof.

### Claim 12 (depends on 11)

The composition of claim 11, wherein the said arachidonic acid or ester thereof comprises at least about 10 percent replacement of hydrogen with deuterium at the mono-allylic sites.

### Claim 13 (depends on 2)

The composition of claim 2, wherein said fatty acid or ester thereof is eicosapentaenoic acid or ester thereof.

### Claim 14 (depends on 2)

The composition of claim 2, wherein said fatty acid or ester thereof is docosahexaenoic acid or ester thereof.

### Claim 15 (depends on 14)

The composition of claim 14, wherein said docohexanenoic acid or ester thereof comprises at least about 5 percent replacement of hydrogen with deuterium at the mono-allylic sites.

### Claim 16 (depends on 2)

The composition of claim 2, wherein said fatty acid or ester thereof is linolenic acid or ester thereof.

### Claim 17 (depends on 2)

The composition of claim 2, wherein said fatty acid or ester thereof is represented by the formula:
where R1 is hydrogen or C1-C10 alkyl;
R2 is —OH, —OR3, —SR3, phosphate or —N(R3)2;
each R3 is independently selected from C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, C3-C10 cycloalkyl, C6-C10 aryl, 4-10 membered heteroaryl, 3 to 10 membered heterocyclic ring;
n is an integer from 3 to 10; and
p is an integer from 1 to 10.

### Claim 18 (depends on 2)

The composition of claim 2, wherein said fatty acid ester is a monoglyceride, a di-glyceride or a triglyceride, or an ethyl ester.
